Q2 2023 · 13F-HR
ACUTA CAPITAL PARTNERS, LLCholdings as filed
Filed 2023-08-14 · accession 0001104659-23-090924
$147.6M
Reported value
35
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $27.1M | 18.4% | 297,596 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCES INC | $12.6M | 8.57% | 1,849,402 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $8.5M | 5.75% | 970,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC. COMMON STOCK | $7.5M | 5.08% | 709,118 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $6.3M | 4.25% | 299,841 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $6.2M | 4.20% | 139,500 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $6.1M | 4.13% | 122,166 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $6.1M | 4.12% | 306,194 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $5.3M | 3.62% | 224,707 | Common | SOLE |
| 46583P102 | — | IVERIC BIO INC | $5.2M | 3.50% | 131,454 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $4.9M | 3.32% | 12,568 | Common | SOLE |
| 74006W108 | — | PRAXIS PRECISION MEDICINES I | $4.9M | 3.31% | 4,250,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $4.8M | 3.27% | 147,318 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC. COMMON STOCK | $4.7M | 3.19% | 430,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC | $4.2M | 2.81% | 122,343 | Common | SOLE |
| 185634102 | CLNNEUR | CLENE INC | $3.7M | 2.53% | 4,240,846 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $3.7M | 2.48% | 558,000 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $3.3M | 2.25% | 382,000 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $2.9M | 1.97% | 244,828 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.7M | 1.82% | 141,755 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $2.2M | 1.51% | 300,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $2.2M | 1.50% | 220,000 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $2.1M | 1.44% | 104,500 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.4M | 0.95% | 44,689 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS | $1.3M | 0.85% | 121,692 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $1.1M | 0.73% | 63,078 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HOLDING INC | $1.0M | 0.68% | 17,500 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS INC | $980,650 | 0.66% | 27,500 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $955,500 | 0.65% | 105,814 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $878,000 | 0.59% | 40,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $821,250 | 0.56% | 73,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $739,332 | 0.50% | 373,400 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $633,054 | 0.43% | 198,139 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $541,800 | 0.37% | 315,000 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $15,023 | 0.01% | 90,832 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.